Posted on Jun 8, 2022
Advisers to the FDA back Novavax COVID vaccine
660
3
2
2
2
0
Posted >1 y ago
Responses: 2
PO1 William "Chip" Nagel
..."The Novavax vaccine uses copies of the SARS-CoV-2 spike protein produced in a factory rather than snippets of genetic code to instruct the body's cells to make the protein that prompts an immune response. Both approaches have proved succesful against COVID-19.
There is some evidence the Novavax vaccine may cause a rare swelling of the heart that also occurs sometimes in people who get one of the other COVID-19 vaccines. The problem has also been seen with mRNA vaccines. But the committee concluded that the benefits of the Novavax vaccine outweigh the risks.
The FDA typically follows the recommendations of its advisers but isn't bound to do so.
If the agency authorizes the Novavax vaccine, the final step before it could be rolled out would be an endorsement by the Centers for Disease Control and Prevention."
..."The Novavax vaccine uses copies of the SARS-CoV-2 spike protein produced in a factory rather than snippets of genetic code to instruct the body's cells to make the protein that prompts an immune response. Both approaches have proved succesful against COVID-19.
There is some evidence the Novavax vaccine may cause a rare swelling of the heart that also occurs sometimes in people who get one of the other COVID-19 vaccines. The problem has also been seen with mRNA vaccines. But the committee concluded that the benefits of the Novavax vaccine outweigh the risks.
The FDA typically follows the recommendations of its advisers but isn't bound to do so.
If the agency authorizes the Novavax vaccine, the final step before it could be rolled out would be an endorsement by the Centers for Disease Control and Prevention."
(1)
(0)
Read This Next